Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

1.

NSAIDs in paediatrics: caution with varicella!

Durand L, Sachs P, Lemaitre C, Lorrot M, Bassehila J, Bourdon O, Prot-Labarthe S.

Int J Clin Pharm. 2015 Aug 22. [Epub ahead of print]

PMID:
26297238
2.

Development of a consensus-base list of criteria for prescribing medication in a pediatric population.

Guérin A, Bussières JF, Boulkedid R, Bourdon O, Prot-Labarthe S.

Int J Clin Pharm. 2015 May 28. [Epub ahead of print]

PMID:
26017398
3.

High-alert medications in a French paediatric university hospital.

Bataille J, Prot-Labarthe S, Bourdon O, Joret P, Brion F, Hartmann JF.

J Eval Clin Pract. 2015 Apr;21(2):262-70. doi: 10.1111/jep.12302. Epub 2015 Jan 6.

PMID:
25560989
4.

Fluoroquinolones in pediatrics: review of hospital prescription use over 2 years.

Genuini M, Prot-Labarthe S, Bourdon O, Doit C, Aujard Y, Naudin J, Lorrot M.

Int J Clin Pharmacol Ther. 2014 Nov;52(11):940-7. doi: 10.5414/CP202103.

PMID:
25161154
5.

[Evaluation of the impact of a training program on vitamin K antagonists (VKA) implemented by pharmacy students aiming at improving the knowledge of patients receiving vitamin K antagonists during their hospital clinical training course].

Conort O, Siguret V, Bourdon O, Nazaraly S, Brignone M, Pons-Kerjean N, Houze S, Laribe Cage S, Berthet F, Golmard JL, Brion F, Tilleul P.

Ann Pharm Fr. 2014 Jul;72(4):287-95. doi: 10.1016/j.pharma.2014.02.004. Epub 2014 Mar 27. French.

PMID:
24997889
6.

POPI (Pediatrics: Omission of Prescriptions and Inappropriate prescriptions): development of a tool to identify inappropriate prescribing.

Prot-Labarthe S, Weil T, Angoulvant F, Boulkedid R, Alberti C, Bourdon O.

PLoS One. 2014 Jun 30;9(6):e101171. doi: 10.1371/journal.pone.0101171. eCollection 2014. Erratum in: PLoS One. 2014;9(9):e108007.

7.

[Determinants of the evolution of hospital pharmacy in France and Quebec: Perception of hospital pharmacists].

Guérin A, Lebel D, Marando N, Prot-Labarthe S, Bourdon O, Bussières JF.

Ann Pharm Fr. 2014 May;72(3):202-15. doi: 10.1016/j.pharma.2014.01.001. Epub 2014 Mar 12. French.

PMID:
24780836
8.

[Treatment of scabies and Ascabiol(®) supply disruption: what about the pediatric population?].

Berthe-Aucejo A, Prot-Labarthe S, Pull L, Lorrot M, Touratier S, Trout H, Bourdon O, Dehen L, Bourrat E.

Arch Pediatr. 2014 Jun;21(6):670-5. doi: 10.1016/j.arcped.2014.03.001. Epub 2014 Apr 24. French.

PMID:
24768069
9.

Paediatric clinical research from the perspective of hospital pharmacists from France and Canada.

Guérin A, Tanguay C, Lebel D, Prot-Labarthe S, Bourdon O, Bussières JF.

Int J Pharm Pract. 2014 Dec;22(6):415-23. doi: 10.1111/ijpp.12099. Epub 2014 Mar 6.

PMID:
24602206
10.

[Is pediatrics excluded from pharmaceutical innovation?].

Hébert G, Prot-Labarthe S, Tremblay ME, Bussières JF, Bourdon O.

Arch Pediatr. 2014 Mar;21(3):245-50. doi: 10.1016/j.arcped.2013.12.016. Epub 2014 Jan 23. French.

PMID:
24462297
11.

[Can you do away with anti-nausea drugs in pediatrics?].

Prot-Labarthe S, Morel D, Bellaïche M, Bourdon O.

Arch Pediatr. 2014 Mar;21(3):326-7. doi: 10.1016/j.arcped.2013.12.006. Epub 2014 Jan 20. French. No abstract available.

PMID:
24457111
12.

[How to improve supervision of carbapenem's prescriptions? Development of a cross-disciplinary computerized system].

Berthe-Aucejo A, Papon A, Doit C, Costa J, Bourdon O.

Presse Med. 2014 Feb;43(2):219-21. doi: 10.1016/j.lpm.2013.04.020. Epub 2013 Nov 8. French. No abstract available.

PMID:
24216052
13.

Pilot Study on the Impact of Evidence-Based Data on Oncology Pharmacists' Perceptions.

Renet S, Lebel D, Prot-Labarthe S, Therrien R, Bourdon O, Bussières JF.

J Pharm Pract. 2013 Oct 15;27(4):358-363. [Epub ahead of print]

PMID:
24128785
14.

Randomized controlled trial of parent therapeutic education on antibiotics to improve parent satisfaction and attitudes in a pediatric emergency department.

Angoulvant F, Rouault A, Prot-Labarthe S, Boizeau P, Skurnik D, Morin L, Mercier JC, Alberti C, Bourdon O.

PLoS One. 2013 Sep 26;8(9):e75590. doi: 10.1371/journal.pone.0075590. eCollection 2013.

15.

How to improve the implementation of academic clinical pediatric trials involving drug therapy? A qualitative study of multiple stakeholders.

Girard D, Bourdon O, Abdoul H, Prot-Labarthe S, Brion F, Tibi A, Alberti C.

PLoS One. 2013 May 28;8(5):e64516. doi: 10.1371/journal.pone.0064516. Print 2013.

16.

Pediatric drug-related problems: a multicenter study in four French-speaking countries.

Prot-Labarthe S, Di Paolo ER, Lavoie A, Quennery S, Bussières JF, Brion F, Bourdon O.

Int J Clin Pharm. 2013 Apr;35(2):251-9. doi: 10.1007/s11096-012-9740-1. Epub 2012 Dec 22.

PMID:
23263797
17.

Drug shortages: what does france do better than Canada?

Barthélémy I, Bussières JF, Lebel D, Gaudreault P, Prot-Labarthe S, Bourdon O.

Can J Hosp Pharm. 2012 Sep;65(5):406-7. No abstract available.

18.

The role of community pharmacists in the management of hematopoietic stem cell transplant recipients: knowledge and training.

Prot-Labarthe S, Stil-Baudry J, Fahd M, Brion F, Bourdon O.

J Pediatr Hematol Oncol. 2013 Apr;35(3):188-92. doi: 10.1097/MPH.0b013e3182707aff.

PMID:
23042014
19.

Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases.

Chauny JV, Lorrot M, Prot-Labarthe S, De Lauzanne A, Doit C, Géréral T, Bourdon O.

Pediatr Infect Dis J. 2012 Dec;31(12):1309-11. doi: 10.1097/INF.0b013e318269cc6a.

PMID:
22814964
20.

[Prioritization of healthcare programs by pharmacy students from France and from Quebec, according to the perceived impact of a decentralized pharmacist].

Renet S, Rochais É, Bussières JF, Lebel D, Tanguay C, Bourdon O.

Ann Pharm Fr. 2012 Mar;70(2):94-103. doi: 10.1016/j.pharma.2012.01.001. Epub 2012 Feb 15. French.

PMID:
22500961
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk